Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.
Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.
Recruiting · NCT06882824 · Registry updated 2025-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol. | Blood Loss, Surgical, Hemorrhage, Intraoperative Complications, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, connective tissue neoplasm, myofibroma, neoplasm | Recruiting | Not applicable | 2025-09-24 | NCT06882824 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital, Clermont-Ferrand | 171 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Clermont-Ferrand | Clermont-Ferrand | France | 1 |